Consolidated Statement Of Cash Flows

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7726293

Concept As at
2018-02-28
2017-03-01 to
2018-02-28
As at
2017-02-28
2016-03-01 to
2017-02-28
As at
2016-02-29
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
36,180,000,000 JPY
30,194,000,000 JPY
Interest and dividends received
1,240,000,000 JPY
984,000,000 JPY
Interest paid
-32,000,000 JPY
-39,000,000 JPY
Income taxes paid
-6,935,000,000 JPY
-11,228,000,000 JPY
Net cash provided by (used in) operating activities
30,453,000,000 JPY
19,910,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-3,131,000,000 JPY
-3,125,000,000 JPY
Proceeds from sale of property, plant and equipment
82,000,000 JPY
54,000,000 JPY
Purchase of investment securities
-691,000,000 JPY
-493,000,000 JPY
Net cash provided by (used in) investing activities
-1,378,000,000 JPY
1,070,000,000 JPY
Proceeds from collection of loans receivable
6,000,000 JPY
7,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-2,000,000 JPY
-11,153,000,000 JPY
Dividends paid
-6,855,000,000 JPY
-6,944,000,000 JPY
Dividends paid to non-controlling interests
-59,000,000 JPY
-50,000,000 JPY
Repayments of long-term borrowings
-71,000,000 JPY
-78,000,000 JPY
Net cash provided by (used in) financing activities
-7,153,000,000 JPY
-18,402,000,000 JPY
Other, net
-64,000,000 JPY
-60,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
-963,000,000 JPY
-909,000,000 JPY
Net increase (decrease) in cash and cash equivalents
20,959,000,000 JPY
1,669,000,000 JPY
Cash and cash equivalents
126,569,000,000 JPY
105,610,000,000 JPY
103,940,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.